These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8794980)

  • 21. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
    Telko MJ; Kujanpää J; Hickey AJ
    Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
    Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
    Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W; Martin GP; Larhrib H; Ticehurst MD; Kolosionek E; Nokhodchi A
    Colloids Surf B Biointerfaces; 2012 Jan; 89():29-39. PubMed ID: 21962946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid interrogation of the physical and chemical characteristics of salbutamol sulphate aerosol from a pressurised metered-dose inhaler (pMDI).
    Tong HJ; Fitzgerald C; Gallimore PJ; Kalberer M; Kuimova MK; Seville PC; Ward AD; Pope FD
    Chem Commun (Camb); 2014 Dec; 50(98):15499-502. PubMed ID: 25329335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K; Inagaki Y; Todo H; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):938-42. PubMed ID: 15304985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristic analysis on temporal evolution of floc size and structure in low-shear flow.
    He W; Nan J; Li H; Li S
    Water Res; 2012 Feb; 46(2):509-20. PubMed ID: 22137291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
    J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW; Lim LT; Heng PW
    J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel quality by design tools for concentrated drug suspensions: surface energy profiling and the fractal concept of flocculation.
    de Kruif JK; Khoo J; Bravo R; Kuentz M
    J Pharm Sci; 2013 Mar; 102(3):994-1007. PubMed ID: 23280339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in fractal dimension during aggregation.
    Chakraborti RK; Gardner KH; Atkinson JF; Van Benschoten JE
    Water Res; 2003 Feb; 37(4):873-83. PubMed ID: 12531269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Pharm Res; 2006 Sep; 23(9):2200-9. PubMed ID: 16900411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheology of cellulose nanofibrils in the presence of surfactants.
    Quennouz N; Hashmi SM; Choi HS; Kim JW; Osuji CO
    Soft Matter; 2016 Jan; 12(1):157-64. PubMed ID: 26466557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS; Biradar SV; Paradkar AR; York P
    Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Malick WA; Madan PL
    Pharm Dev Technol; 1998 May; 3(2):163-74. PubMed ID: 9653753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.
    Corrigan DO; Healy AM; Corrigan OI
    Eur J Pharm Biopharm; 2006 Apr; 62(3):295-305. PubMed ID: 16314079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D; Young PM; Jones M; Edge S; Price R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.